Monday, July 25, 2011
Cord Blood and Hearing Loss - First Clinical Trial Underway
Several studies have found that using stem cells to help regenerate parts of the inner ear to be largely successful. However, this study is the first of its kind to use a child’s own cord blood to treat their hearing loss. There are currently no known treatments for hearing loss.
Only children six weeks to 18 months of age with cord blood banked at Cord Blood Registry are eligible to take part in the study. The hearing loss must be acquired and cannot be genetic. Only ten children will be able to take part. For more information and to register for the clinical trial, click here.
Do you have a child with hearing loss?
Safety of Autologous Human Umbilical Cord Blood Mononuclear Fraction to Treat Acquired Hearing Loss in Children [NIH]
Sensorineural Hearing Loss [ASHA]
Can Stem Cells Cure Deafness? [Hearing Loss Web]
Cord Blood Clinical Trials Overview [CBR]